89 related articles for article (PubMed ID: 25350514)
1. Scopine as a novel brain-targeting moiety enhances the brain uptake of chlorambucil.
Wang X; Li J; Xu C; Li Y; Gong T; Sun X; Fu Y; He Q; Zhang Z
Bioconjug Chem; 2014 Nov; 25(11):2046-54. PubMed ID: 25350514
[TBL] [Abstract][Full Text] [Related]
2. Validated LC-MS/MS method for the simultaneous determination of chlorambucil and its prodrug in mouse plasma and brain, and application to pharmacokinetics.
Wang X; Zhang Q; Lin Q; Zhang Y; Zhang ZR
J Pharm Biomed Anal; 2014 Oct; 99():74-8. PubMed ID: 25090578
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and in vitro efficacy of transferrin conjugates of the anticancer drug chlorambucil.
Beyer U; Roth T; Schumacher P; Maier G; Unold A; Frahm AW; Fiebig HH; Unger C; Kratz F
J Med Chem; 1998 Jul; 41(15):2701-8. PubMed ID: 9667961
[TBL] [Abstract][Full Text] [Related]
4. Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals.
Du J; Lu WL; Ying X; Liu Y; Du P; Tian W; Men Y; Guo J; Zhang Y; Li RJ; Zhou J; Lou JN; Wang JC; Zhang X; Zhang Q
Mol Pharm; 2009; 6(3):905-17. PubMed ID: 19344115
[TBL] [Abstract][Full Text] [Related]
5. Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals.
Ying X; Wen H; Lu WL; Du J; Guo J; Tian W; Men Y; Zhang Y; Li RJ; Yang TY; Shang DW; Lou JN; Zhang LR; Zhang Q
J Control Release; 2010 Jan; 141(2):183-92. PubMed ID: 19799948
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and pharmacodynamics of chlorambucil delivered in parenteral emulsion.
Ganta S; Paxton JW; Baguley BC; Garg S
Int J Pharm; 2008 Aug; 360(1-2):115-21. PubMed ID: 18508212
[TBL] [Abstract][Full Text] [Related]
7. LDLR-mediated peptide-22-conjugated nanoparticles for dual-targeting therapy of brain glioma.
Zhang B; Sun X; Mei H; Wang Y; Liao Z; Chen J; Zhang Q; Hu Y; Pang Z; Jiang X
Biomaterials; 2013 Dec; 34(36):9171-82. PubMed ID: 24008043
[TBL] [Abstract][Full Text] [Related]
8. Development of lipophilic anticancer agents for the treatment of brain tumors by the esterification of water-soluble chlorambucil.
Genka S; Deutsch J; Shetty UH; Stahle PL; John V; Lieberburg IM; Ali-Osman F; Rapoport SI; Greig NH
Clin Exp Metastasis; 1993 Mar; 11(2):131-40. PubMed ID: 8444006
[TBL] [Abstract][Full Text] [Related]
9. Decreased cytotoxicity and increased antimitotic activity of a proline analogue of chlorambucil as a prodrug susceptible to the action of fibroblast's prolidase.
Bielawska A; Chrzanowski K; Bielawski K; Pałka J
Pharmazie; 2001 Apr; 56(4):290-4. PubMed ID: 11338665
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biophysical characterization of chlorambucil anticancer ether lipid prodrugs.
Pedersen PJ; Christensen MS; Ruysschaert T; Linderoth L; Andresen TL; Melander F; Mouritsen OG; Madsen R; Clausen MH
J Med Chem; 2009 May; 52(10):3408-15. PubMed ID: 19402667
[TBL] [Abstract][Full Text] [Related]
11. Novel molecular anti-colorectalcancer conjugate:chlorambucil-adipic acid dihydrizide-glutamine.
Tabasi MA; Amanlou M; Siadat SD; Nourmohammadi Z; Omoomi FD; Ebrahimi SE; Aghasadeghi MR; Rahimi P; Pourhosseini S; Mehravi B; Ardestani MS
Anticancer Agents Med Chem; 2013 Nov; 13(9):1449-59. PubMed ID: 23343080
[TBL] [Abstract][Full Text] [Related]
12. Large amino acid transporter 1 (LAT1) prodrugs of valproic acid: new prodrug design ideas for central nervous system delivery.
Peura L; Malmioja K; Laine K; Leppänen J; Gynther M; Isotalo A; Rautio J
Mol Pharm; 2011 Oct; 8(5):1857-66. PubMed ID: 21770378
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and pharmacodynamics of chlorambucil delivered in long-circulating nanoemulsion.
Ganta S; Sharma P; Paxton JW; Baguley BC; Garg S
J Drug Target; 2010 Feb; 18(2):125-33. PubMed ID: 19728787
[TBL] [Abstract][Full Text] [Related]
14. DNA crosslinking and biological activity of a hairpin polyamide-chlorambucil conjugate.
Wang YD; Dziegielewski J; Wurtz NR; Dziegielewska B; Dervan PB; Beerman TA
Nucleic Acids Res; 2003 Feb; 31(4):1208-15. PubMed ID: 12582240
[TBL] [Abstract][Full Text] [Related]
15. Two novel nucleoside ester derivatives of chlorambucil as potential antileukemic prodrugs: a preliminary study.
Kryczka T; Kazimierczuk Z; Kozłowska M; Chrapusta SJ; Vilpo L; Vilpo J; Stachnik K; Janisz M; Grieb P
Anticancer Drugs; 2007 Mar; 18(3):301-10. PubMed ID: 17264763
[TBL] [Abstract][Full Text] [Related]
16. Novel brain targeting prodrugs of naproxen based on dimethylamino group with various linkages.
Zhang Q; Liang Z; Chen LY; Sun X; Gong T; Zhang ZR
Arzneimittelforschung; 2012 Jun; 62(6):261-6. PubMed ID: 22407924
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxic activity of G3 PAMAM-NH₂ dendrimer-chlorambucil conjugate in human breast cancer cells.
Bielawski K; Bielawska A; Muszyńska A; Popławska B; Czarnomysy R
Environ Toxicol Pharmacol; 2011 Nov; 32(3):364-72. PubMed ID: 22004955
[TBL] [Abstract][Full Text] [Related]
18. Physicochemical and pharmacokinetic parameters of seven lipophilic chlorambucil esters designed for brain penetration.
Greig NH; Genka S; Daly EM; Sweeney DJ; Rapoport SI
Cancer Chemother Pharmacol; 1990; 25(5):311-9. PubMed ID: 2306790
[TBL] [Abstract][Full Text] [Related]
19. A novel lactoferrin-modified β-cyclodextrin nanocarrier for brain-targeting drug delivery.
Ye Y; Sun Y; Zhao H; Lan M; Gao F; Song C; Lou K; Li H; Wang W
Int J Pharm; 2013 Dec; 458(1):110-7. PubMed ID: 24126038
[TBL] [Abstract][Full Text] [Related]
20. Structure-anti-leukemic activity relationship study of B- and D-ring modified and non-modified steroidal esters of chlorambucil.
Fousteris MA; Koutsourea AI; Arsenou ES; Papageorgiou A; Mourelatos D; Nikolaropoulos SS
Anticancer Drugs; 2006 Jun; 17(5):511-9. PubMed ID: 16702807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
